Deep Genomics, the Toronto-based AI therapeutics startup, has made the first-ever discovery of a diseases treatment and drug candidate using artificial intelligence. The startup announced on Wednesday that its propriety AI-based drug discovery platform has identified a novel treatment target and corresponding drug candidate for Wilson disease, a rare and potentially life-threatening genetic disorder. "Our AI systems can figure out how diseases are caused and how to fix those diseases much more rapidly than humans ever could." "This is the amazing accomplishment for the team," Brendan Frey, founder and CEO of Deep Genomics, told BetaKit. He noted that part of Deep Genomic's goal is to "help everyone in the world" use the discovery and technology its developing in Canada to support discovery and development more broadly.

If you're like the majority of humans on the planet, going to the dentist isn't on the top of your list of things to do for fun. But with artificial intelligence (AI) and new tech and innovative design, it might start to be a bit more intriguing. AI might not be able to do the actual brushing and flossing for you (yet), but it will certainly change your experience the next time you're sitting in the dentist's chair. From analysing X-rays to documenting the results of your visit, artificial intelligence will be relied upon to make your dental appointment more efficient and to enhance your care. Dentem created a platform that integrates machine learning APIs, including the ability to auto-populate tooth charting.

On February 6, 2018, Elon Musk's SpaceX launched the Falcon Heavy rocket, the largest ever, from NASA's Kennedy Space Center. Its cargo was a Tesla Roadster, which is now orbiting the sun somewhere between Mars and the asteroid belt. Between Elon Musk's numerous companies and passion projects (SpaceX, Tesla, Solar City, the Hyperloop, the Boring Company), and the quickly proceeding advances in VR/AR/MR, genetics/cloning, blockchain, AI, 3D printing, and other fields, someone who was in a coma since 1998 and just woke up yesterday would be forgiven for thinking they had jumped a hundred years into the future instead of a mere 20. But then this person would actually get up and go out into the real world and see that mostly everything else is the same, aside from more traffic on the roads, more people in general, most of whom now carry miniature computers with them wherever they go that are more powerful than any desktop from the 20th century. Born in apartheid-era South Africa, he lived the first 16 years of his life in various towns, including Pretoria, moving back and forth between divorced parents.

The Energy Department unveiled plans to launch a $5.5 million research center that will bring together top thinkers from three federal and academic institutions to solve some of the world's most complex challenges in artificial intelligence. Researchers from Energy's Pacific Northwest National Laboratory, Sandia National Laboratories, and the Georgia Institute of Technology will join forces in the newly unveiled Center for Artificial Intelligence-Focused Architectures and Algorithms, or ARIAA. "AI will allow us to solve problems today, that simply cannot be solved because they are too complex," said Roberto Gioiosa, the senior research scientist at PNNL selected lead the new center. "This is the science of the future." The move follows Energy Secretary Rick Perry's recent announcement that the agency is working to establish an Artificial Intelligence and Technology Office to coordinate and streamline the agency's efforts and growing investments around AI.

"I want people to have the awareness of the issues affecting Japan," says University of Tsukuba Associate Professor Yoichi Ochiai. Artificial intelligence, 5G wireless networks, and other technologies can be harnessed to address social challenges unique to Japan, says Yoichi Ochiai, an associate professor at the University of Tsukuba and CEO of Pixie Dust Technologies Inc. The 5G network is set to enter commercial service in Japan next spring. It will "have an enormous impact on our communication media . . . Improving the service infrastructure for the elderly, including taxi-hailing apps and automatic transcriptions for those with hearing difficulty, is vital to independent living, Ochiai says.

In a suburb of Phoenix, Arizona, there's a fleet of 600 minivans shuttling people from place to place. Ordering one feels almost exactly like calling an Uber, except for one thing: the vans are driving themselves. Alphabet's Waymo has been testing self-driving vehicles in Arizona since 2017 and we got an inside look at what it's like. Watch the video to find out more.

The pace and scale of medical and scientific innovation is transforming the biopharma industry. The need for better patient engagement and experience is spurring new business models. Data generated, captured, analysed and used in real time by innovative medical devices is biopharma's new currency. A key differentiator for companies is the extent to which they are able to generate insights and evidence from multiple data sources. Consequently, digital transformation is a strategic imperative. This report outlines how artificial intelligence-enabled technologies will impact the biopharma value chain and accelerate biopharma's digital transformation. Although there is a high level of innovation in the industry, biopharma companies are facing a complex and challenging environment due to increased competition and R&D cycle times, shorter time in market, expiring patents, declining peak sales, pressure around reimbursement and mounting regulatory scrutiny. As we have shown in our series of reports on'Measuring the return from pharmaceutical innovation', these factors are contributing to an alarming decline in the projected return on investment that large biopharma companies might expect to achieve from their late-stage pipelines, threatening their long-term futures.1 Digital transformation could provide a lifeline to biopharma research and development (R&D) and help reverse this trend. Digital transformation will also impact beyond R&D, as companies look to improve their operational performance, productivity, efficiency and cost-effectiveness across the entire biopharma value chain (see figure 1). Digital transformation will also impact business models, the development of new products and services, and how companies engage with health care professionals, patients and other customers. Ultimately, digital transformation is the next step in the evolution of biopharma companies.

The brilliant 2007 science fiction novel "The Three-Body Problem," by the Chinese writer Liu Cixin, depicts the fate of civilizations as almost entirely dependent on winning grand races to scientific milestones. Someone in China's leadership must have read that book, for Beijing has made winning the race to artificial intelligence a national obsession, devoting billions of dollars to the cause and setting 2030 as the target year for world dominance. Not to be outdone, President Vladimir Putin of Russia recently declared that whoever masters A.I. "will become the ruler of the world." To be sure, the bold promises made by A.I.'s true believers can seem excessive; today's A.I. technologies are useful only in narrow situations. But if there is even a slim chance that the race to build stronger A.I. will determine the future of the world -- and that does appear to be at least a possibility -- the United States and the rest of the West are taking a surprisingly lackadaisical and alarmingly risky approach to the technology.

By Avik Chanda In 2013, as a fresh B. Tech graduate, Shranik Jain lived and breathed only technology – his chief interests at that time were all centred around the intricacies of Intel's 3D Tri Gate Transistor. But six years on, his work as a Product Manager for IndiaMART InterMESH Limited has taken him to an area that traditionally wouldn't have been in the remit of his job description. "Over the years, significant changes have taken place in the product management role," explains Shranik. "We are now focusing majorly on User Experience Design. The primary emphasis is on customer empathy, while leveraging techniques like machine learning, thereby assisting us in better decision making."

Fox News Flash top headlines for Oct. 7 are here. Check out what's clicking on Foxnews.com A plane passenger -- who works as a legal analyst on sexual assault, harassment and discrimination cases -- has claimed on Twitter that she was the victim of sexual harassment aboard a recent Virgin Atlantic flight. Jessica Van Meir, who is from Atlanta but living in the U.K., wrote of the alleged incident, which reportedly happened Saturday, on her social media page. According to Van Meir, she was in her seat when someone else on the flight messaged her using the plane's seat-to-seat messaging function.